Sorrento Therapeutics in the United States has found a
coronavirus antibody that has been shown in the laboratory to be able to
prevent 100% of infections. The results of that pre-clinical lab test have now
made people optimistic.
Sorrento Therapeutics Inc., a small-scale biopharmaceutical
company in the United States, primarily studies human therapeutic antibodies
for the treatment of cancer, inflammation, digestion, and infectious diseases.
A report by Business Insider, a US business and technology
website, said the company's share price rose 244 percent on Friday after it
claimed to have discovered the Covid-19 antibody. Researchers at the institute
claim that pre-clinical trials of antibodies they have found have been shown to
be 100% effective against the virus in the laboratory.
The company said it would develop an antibody cocktail that
would act as a "protective shield" against the coronavirus. The
results of their test will soon be submitted to a peer review journal. In
addition the regulators will ask the antibody to evaluate the candidate's
preferences and conduct a speedy review. If clinical research seems successful,
they will work with pharmaceutical companies, governments and partners to
increase production.
he market value of Sorrento stood at crore 549 million on
Thursday, while on Friday it stood at crore 9 billion.
The technology website TechCrunch reports that it was an in
vitro lab test that did not apply antibodies to any actual human body. Yet it
is a potential innovation. Because, the company is working on making an
antibody cocktail, which can provide protection against the virus even after
mutation.
Sorrento said the antibody, called STI-1499, came out of
their test, which completely blocked the interaction of SARS-Cove-2 spike proteins
with human cells. This means that it prevents the virus from infecting the
healthy cells of the host.
Sorrento's covid-shield is meant to deal with a powerful
mixture of different antibodies, which will protect against various attacks of
the virus. However, the agency said it would also seek the approval of the US
Food and Drug Administration (FDA) to develop STI-1499 antibodies as a single
therapy.
TechCrunch says it is important to be careful that there is
no cure or vaccine magic bullet in the treatment of SARS-Cov-2 or Covid-19. But
it is still a promising discovery that needs to be kept in mind in clinical
trials and control processes.
